Canada markets close in 6 hours

Shanghai Bio-heart Biological Technology Co., Ltd. (2185.HK)

HKSE - HKSE Delayed Price. Currency in HKD
Add to watchlist
2.100+0.020 (+0.96%)
At close: 03:48PM HKT
Full screen
Previous Close2.080
Open2.190
Bid2.080 x N/A
Ask2.100 x N/A
Day's Range2.100 - 2.190
52 Week Range1.790 - 5.700
Volume38,600
Avg. Volume45,954
Market Cap527.375M
Beta (5Y Monthly)-0.45
PE Ratio (TTM)N/A
EPS (TTM)-0.790
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023

    Bioheart (02185.HK), together with its holding subsidiary Angiocare announces the clinical result for Iberis-HTN at China Interventional Therapeutics 2023. Iberis-HTN is a prospective, multicenter, blinded, randomized controlled trial to evaluate the safety and efficacy of the Iberis® Multi-Electrode Renal Artery Radiofrequency Ablation Catheter System for the treatment of primary hypertension (NCT02901704). The study was led by Academician Runlin GAO and Professor Xiongjing JIANG from Fuwai Hos